Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Hevylite and Freelite Tests in Newly Diagnosed Multiple Myeloma: Clinical Utility and Correlations with Clinical Features

Blood (2016) 128 (22): 5625.

https://doi.org/10.1182/blood.V128.22.5625.5625

Published: 2016

Journal Articles

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Blood (2015) 126 (23): 927.

https://doi.org/10.1182/blood.V126.23.927.927

Published: 2015

Journal Articles

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Blood (2013) 122 (21): 685.

https://doi.org/10.1182/blood.V122.21.685.685

Published: 2013

Journal Articles

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Marco Ladetto, Gloria Pagliano, Ilaria Avonto, Loredana Santo, Simone Ferrero, Federica Cavallo, Monica Astolfi, Patrizia Pregno, Claudia Crippa, Anna Marina Liberati, Vincenzo Callea, Luca De Rosa, Antonietta Falcone, Mariella Grasso, Daniela Drandi, Mario Boccadoro, Antonio Palumbo

Blood (2007) 110 (11): 530.

https://doi.org/10.1182/blood.V110.11.530.530

Published: 2007

Journal Articles

Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2.

Marco Ladetto, Daniela Drandi, Loredana Santo, Barbara Mantoan, Michela Boi, Maria Dell’Aquila, Luigia Monitillo, Chiara Lobetti Bodoni, Antonio Palumbo, MD, Monica Astolfi, Mario Boccadoro

Blood (2006) 108 (11): 3413.

https://doi.org/10.1182/blood.V108.11.3413.3413

Published: 2006

Journal Articles

Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR.

Marco Ladetto, Monica Astolfi, Loredana Santo, Ilaria Avonto, Federica Cavallo, Gloria Pagliano, Patrizia Pregno, Mariella Grasso, Anna Marina Liberati, Tommaso Caravita, Francesco Pisani, Tommasina Guglielmelli, Elisa Genuardi, Rossana Crivelli, Carmen Cristiano, Daniela Drandi, Mario Boccadoro, Antonio Palumbo

Blood (2006) 108 (11): 3100.

https://doi.org/10.1182/blood.V108.11.3100.3100

Published: 2006

Journal Articles

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Daniela Drandi, Marco Ladetto, Sonia Vallet, Loredana Santo, Irene Ricca, Maria Dell’Aquila, Luigia Monitillo, Monica Astolfi, Marina Ruggeri, Maria Teresa Ambrosini, Federica De Marco, Lydia Marino, Barbara Mantoan, Gloria Pagliano, Paola Omedè, Antonio Palumbo, Mario Boccadoro.

Blood (2005) 106 (11): 5088.

https://doi.org/10.1182/blood.V106.11.5088.5088

Published: 2005

Journal Articles

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

Irene Ricca, MD, Alberto Rocci, MD, Daniela Drandi, PhD, Mara Compagno, PhD, Roberto Francese, PhD, Paola Omedè, PhD, Loredana Santo, MD, Michela Rosace, PhD, Federica De Marco, MD, Monica Astolfi, PhD, Chiara Lobetti Bodoni, MD, Maria Dell’Aquila, PhD, Sonia Vallet, MD, Luciana Bergui, MD, Andrea Gallamini, MD, Carlo Marinone, MD, Mario Boccadoro, MD, Corrado Tarella, MD, Marco Ladetto, MD

Blood (2005) 106 (11): 2104.

https://doi.org/10.1182/blood.V106.11.2104.2104

Published: 2005

Journal Articles

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Blood (2005) 105 (12): 4784–4791.

https://doi.org/10.1182/blood-2004-11-4201

Published: 2005

Journal Articles

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Marco Ladetto, Sonia Vallet, Andreas Trojan, Maria Dell’Aquila, Luigia Monitillo, Loredana Santo, Alessandra Bertola, Patrizia Falco, Federica Cavallo, Daniela Drandi, Irene Ricca, Gloria Pagliano, Monica Astolfi, Alberto Rocci, Beata Bode, Antonio Palumbo, Corrado Tarella, Paola Omedé, Mario Boccadoro

Blood (2004) 104 (11): 2450.

https://doi.org/10.1182/blood.V104.11.2450.2450

Published: 2004

Journal Articles

Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival.

Blood (2004) 104 (11): 1320.

https://doi.org/10.1182/blood.V104.11.1320.1320

Published: 2004

Journal Articles

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Marco Ladetto, MD, Barbara Mantoan, PhD, Federica De Marco, MD, Berardino Pollio, MD, Daniela Drandi, PhD, Irene Ricca, MD, Sonia Vallet, MD, Mara Compagno, PhD, Monica Astolfi, PhD, Maria Dell’Aquila, PhD, Roberto Francese, PhD, Gloria Pagliano, PhD, Luigia Monitillo, PhD, Giacomo Tamponi, MD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 1373.

https://doi.org/10.1182/blood.V104.11.1373.1373

Published: 2004

Journal Articles

Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo).

Marco Ladetto, Sonia Vallet, Paolo Corradini, Fabio Benedetti, Umberto Vitolo, Maurizio Martelli, Vincenzo Callea, Paolo Coser, Alessio Perrotti, Caterina Patti, Giuseppe Fioritoni, Sergio Morandi, Maurizio Musso, Renato Zambello, Monica Astolfi, Alessandro Pileri, Mario Boccadoro, Corrado Tarella

Blood (2004) 104 (11): 903.

https://doi.org/10.1182/blood.V104.11.903.903

Published: 2004

Journal Articles

Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines.

Marco Ladetto, MD, Irene Ricca, MD, Mara Compagno, PhD, Dario Ferrero, MD, Alberto Rocci, MD, Maria Dell’Aquila, PhD, Paola Omedè, PhD, Roberto Francese, PhD, Federica De Marco, MD, Sonia Vallet, MD, Loredana Santo, MD, Daniela Drandi, PhD, Monica Astolfi, PhD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 3389.

https://doi.org/10.1182/blood.V104.11.3389.3389

Published: 2004

Journal Articles

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Marco Ladetto, Mara Compagno, Irene Ricca, Marco Pagano, Alberto Rocci, Monica Astolfi, Daniela Drandi, Paola Francia di Celle, Maria Dell'Aquila, Barbara Mantoan, Sonia Vallet, Gloria Pagliano, Federica De Marco, Roberto Francese, Loredana Santo, Alessandra Cuttica, Carlo Marinone, Mario Boccadoro, Corrado Tarella

Blood (2004) 103 (12): 4644–4649.

https://doi.org/10.1182/blood-2003-12-4412

Published: 2004

Journal Articles

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Blood (2002) 100 (5): 1559–1565.

https://doi.org/10.1182/blood-2002-02-0621

Published: 2002

Journal Articles

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Paolo Corradini, Monica Astolfi, Cristina Cherasco, Marco Ladetto, Claudia Voena, Daniele Caracciolo, Alessandro Pileri, Corrado Tarella

Blood (1997) 89 (2): 724.

https://doi.org/10.1182/blood.V89.2.724

Published: 1997

NARROW

Hevylite and Freelite Tests in Newly Diagnosed Multiple Myeloma: Clinical Utility and Correlations with Clinical Features

Extracellular Vesicles as Potential Biomarker for Acute Graft-Versus-Host-Disease

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2.

Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR.

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival.

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo).

Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines.

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only